Mediclinic International plc Holding(s) in Company (0635F)

TIDMMDC

RNS Number : 0635F

Mediclinic International plc

15 May 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

15 May 2017

Notification of Major Interest in Mediclinic International plc shares

 
 1. Identity of the issuer or                                    MEDICLINIC INTERNATIONAL 
  the underlying issuer                                                     PLC 
  of existing shares to which 
  voting rights are 
  attached: 
-----------------------------------------------------------  ------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                 X 
------------------------------------------------------------  ------------------------------ 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------  ------------------------------ 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------  ------------------------------ 
 An event changing the breakdown of voting rights 
------------------------------------------------------------  ------------------------------ 
 Other (please 
  specify): 
----------------------------------------------------------    ------------------------------ 
 3. Full name of person(s)                                    PUBLIC INVESTMENT CORPORATION 
  subject to the                                                        SOC LIMITED 
  notification obligation: 
-----------------------------------------------------------  ------------------------------- 
 4. Full name of shareholder(s)                                            N/A 
  (if different from 3.): 
-----------------------------------------------------------  ------------------------------- 
 5. Date of the transaction                                            11 May 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: 
-----------------------------------------------------------  ------------------------------- 
 6. Date on which issuer                                               12 May 2017 
  notified: 
-----------------------------------------------------------  ------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached:                                                                  8% 
-----------------------------------------------------------  ------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares 
------------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                            Resulting situation after the 
  of              to the triggering                             triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  --------------------------------------------  ----------------------------------------------------------- 
                 Number                      Number            Number      Number of             % of voting 
                 of                          of                of shares    voting                rights 
                 Shares                      Voting                         rights 
                                             Rights 
--------------  --------------------------  ----------------  ----------  --------------------  ------------------------- 
                                                               Direct      Direct     Indirect   Direct        Indirect 
--------------      ---------  -----------      ------------  ----------  ---------  ---------  ------------  ----------- 
                 58 705                                        59 447 
  GB00B8HX8Z88    799                                           726                              8.064% 
                --------------------------  ----------------  ----------  ---------  ---------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration                Exercise/                     Number of voting        % of voting 
  instrument          date                      Conversion                    rights that             rights 
                                                Period                        may be 
                                                                              acquired if 
                                                                              the 
                                                                              instrument 
                                                                              is 
                                                                              exercised/ 
                                                                              converted. 
------------------  ------------------------  ----------------------------  ----------------------  --------------------- 
 NONE                N/A                       N/A                           N/A                     N/A 
------------------  ------------------------  ----------------------------  ----------------------  --------------------- 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise     Expiration       Exercise/       Number of voting                  % of voting 
 financial         price         date             Conversion      rights instrument                 rights 
 instrument                                       period          refers to 
----------------  -----------  ---------------  --------------  --------------------------------  ----------------------- 
                                                                                                   Nominal       Delta 
----------------  -----------  ---------------  --------------  --------------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                         Percentage of voting rights 
--------------------------------------------------------------  --------------------------------------------------------- 
 59 447 726                                                      8.064% 
--------------------------------------------------------------  --------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
---------------------------------------------------------------------------- 
 
   N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------- 
 10. Name of the proxy holder:                            N/A 
-------------------------------------------------------  ------------------- 
 11. Number of voting rights proxy                        N/A 
  holder will cease 
  to hold: 
-------------------------------------------------------  ------------------- 
 12. Date on which proxy holder will                      N/A 
  cease to hold 
  voting rights: 
-------------------------------------------------------  ------------------- 
 
 
  13. Additional information:                              N/A 
-------------------------------------------------------  ------------------- 
 14. Contact name:                                        DEVILLIERS MAKONKO 
-------------------------------------------------------  ------------------- 
 15. Contact telephone number:                            012 742 3578 
-------------------------------------------------------  ------------------- 
 
 

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South

Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

Capita Company Secretarial Services Limited

Victoria Dalby

[phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUUABRBWAVAAR

(END) Dow Jones Newswires

May 15, 2017 03:00 ET (07:00 GMT)